| Product Code: ETC066682 | Publication Date: Aug 2021 | Updated Date: Aug 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
In response to healthcare challenges, the infectious disease point-of-care testing market in Mexico is gaining importance. The need for rapid and decentralized testing for infectious diseases is driving market growth. Government initiatives and advancements in diagnostic technologies play a crucial role in shaping the landscape of point-of-care testing for infectious diseases.
The Mexico Infectious Disease Point-of-care Testing Market is driven by the increasing emphasis on rapid and decentralized diagnostic solutions. The demand for quick and on-the-spot testing has surged, especially during outbreaks or health crises. Government initiatives to control infectious diseases and improve healthcare accessibility in remote areas contribute to the market`s growth.
The infectious disease point-of-care testing market in Mexico faces challenges related to the timely and accurate diagnosis of diseases, especially during health crises. Limited access to testing facilities in remote areas contributes to delayed diagnoses and treatment, exacerbating the spread of infectious diseases. Infrastructure constraints and logistical challenges further hinder the distribution of point-of-care testing devices. Overcoming these challenges requires strategic collaborations between healthcare providers, government agencies, and technology providers to ensure widespread availability and accessibility of testing solutions across the country.
Public health policies in Mexico emphasize the importance of early detection and rapid response to infectious diseases. The government has implemented strategies to increase accessibility to point-of-care testing facilities, facilitating timely diagnosis and treatment. These policies drive the market for infectious disease point-of-care testing.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Infectious Disease Point-of-care Testing Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Infectious Disease Point-of-care Testing Market - Industry Life Cycle |
3.4 Mexico Infectious Disease Point-of-care Testing Market - Porter's Five Forces |
3.5 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.6 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Technologies, 2021 & 2031F |
3.7 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Mexico Infectious Disease Point-of-care Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Mexico |
4.2.2 Growing awareness about the benefits of point-of-care testing for infectious diseases |
4.2.3 Government initiatives to improve healthcare infrastructure and accessibility |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas of Mexico |
4.3.2 Lack of skilled healthcare professionals for conducting point-of-care testing |
4.3.3 Stringent regulatory requirements for approval of point-of-care testing products |
5 Mexico Infectious Disease Point-of-care Testing Market Trends |
6 Mexico Infectious Disease Point-of-care Testing Market, By Types |
6.1 Mexico Infectious Disease Point-of-care Testing Market, By Applications |
6.1.1 Overview and Analysis |
6.1.2 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Applications, 2021-2031F |
6.1.3 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Tropical Disease, 2021-2031F |
6.1.4 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Liver Disease, 2021-2031F |
6.1.5 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Respiratory Disease, 2021-2031F |
6.1.6 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Sexual Disorders, 2021-2031F |
6.1.7 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2021-2031F |
6.2 Mexico Infectious Disease Point-of-care Testing Market, By Technologies |
6.2.1 Overview and Analysis |
6.2.2 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Lateral Flow, 2021-2031F |
6.2.3 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Flow-through, 2021-2031F |
6.2.4 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Agglutination Assays, 2021-2031F |
6.2.5 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Solid Phase, 2021-2031F |
6.3 Mexico Infectious Disease Point-of-care Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Diagnostic Laboratories, 2021-2031F |
6.3.3 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Hospitals, 2021-2031F |
6.3.4 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Home-care Settings, 2021-2031F |
6.3.5 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2021-2031F |
7 Mexico Infectious Disease Point-of-care Testing Market Import-Export Trade Statistics |
7.1 Mexico Infectious Disease Point-of-care Testing Market Export to Major Countries |
7.2 Mexico Infectious Disease Point-of-care Testing Market Imports from Major Countries |
8 Mexico Infectious Disease Point-of-care Testing Market Key Performance Indicators |
8.1 Adoption rate of point-of-care testing technologies in healthcare facilities |
8.2 Percentage of infectious disease cases diagnosed using point-of-care testing |
8.3 Number of training programs conducted to educate healthcare professionals on point-of-care testing techniques |
9 Mexico Infectious Disease Point-of-care Testing Market - Opportunity Assessment |
9.1 Mexico Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.2 Mexico Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Technologies, 2021 & 2031F |
9.3 Mexico Infectious Disease Point-of-care Testing Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 Mexico Infectious Disease Point-of-care Testing Market - Competitive Landscape |
10.1 Mexico Infectious Disease Point-of-care Testing Market Revenue Share, By Companies, 2024 |
10.2 Mexico Infectious Disease Point-of-care Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here